Sven Arne Andréasson
Director/Board Member presso MENDUS AB
Patrimonio netto: - $ in data 31/03/2024
Posizioni attive di Sven Arne Andréasson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MENDUS AB | Director/Board Member | 01/01/2020 | - |
| Independent Dir/Board Member | 01/01/2020 | - | |
| Stefan Forsberg Consulting AB | Corporate Officer/Principal | - | - |
| Galenos SRL | Director/Board Member | 01/01/2014 | - |
| Corporate Officer/Principal | 01/01/2014 | - | |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Director/Board Member | - | - |
| Operations Leadership Oil AB | Chairman | 15/10/2010 | - |
Storia della carriera di Sven Arne Andréasson
Precedenti posizioni note di Sven Arne Andréasson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Director/Board Member | 01/01/2009 | 23/06/2023 |
| Independent Dir/Board Member | 01/01/2009 | 23/06/2023 | |
| NOVAVAX, INC. | Corporate Officer/Principal | 02/06/2014 | 01/05/2023 |
| MENDUS AB | Director/Board Member | 01/01/2013 | 26/05/2016 |
| Independent Dir/Board Member | 01/01/2013 | 26/05/2016 | |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Chief Executive Officer | 01/03/2012 | 01/11/2013 |
| ░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Sven Arne Andréasson
| Stockholm School of Economics | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 14 |
| Belgio | 5 |
| Francia | 4 |
Posizioni
| Director/Board Member | 9 |
| President | 6 |
| Corporate Officer/Principal | 4 |
Settori
| Health Technology | 14 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| ACTIVE BIOTECH AB | Health Technology |
| CANTARGIA AB | Health Technology |
| MENDUS AB | Health Technology |
| Aziende private | 19 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
| Pharmacia AB | Health Technology |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Unibioscreen SA
 Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
| Pharmacia SAS | |
| Kabi Pharmacia | |
| Kabivitrum AB | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
Sista versen 26366 AB
 Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Health Technology |
Beta-Cell NV
 Beta-Cell NV Miscellaneous Commercial ServicesCommercial Services Beta-Cell NV is a Belgian company that offers a cell replacement therapy for diabetes. The private company is based in Brussels, Belgium. The company's therapy provides a cure for diabetes, which affects people of all ages, genders, and ethnicities. | Commercial Services |
| Operations Leadership Oil AB | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
| Galenos SRL | |
| Stefan Forsberg Consulting AB | |
| Advet AB | |
| Advet Production AB | |
Pharmacia Arzneimittel GmbH
 Pharmacia Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Pharmacia Arzneimittel GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ratingen, Germany. | Health Technology |
Kabipharmacia International
 Kabipharmacia International Pharmaceuticals: MajorHealth Technology Kabipharmacia International is a French company that manufactures pharmaceutical products. | Health Technology |
- Borsa valori
- Insiders
- Sven Arne Andréasson
- Esperienza
